Clinical Trials Browser

Urinary Bladder Neoplasms

Infiltrating Bladder Urothelial Carcinoma

Urinary Bladder Neoplasms

Urinary Bladder Neoplasms

Urinary Bladder Neoplasms

Urinary Bladder Neoplasms, Ureteral Neoplasms

Urinary Bladder Neoplasms

Urinary Bladder Neoplasms

Urinary Bladder Neoplasms

Urinary Bladder Neoplasms

Urinary Bladder Neoplasms

Urinary Bladder Diseases, Urinary Bladder Neoplasms, Urologic Diseases, Urologic Neoplasms

Urinary Bladder Neoplasms

Muscle Invasive Bladder Cancer

Urinary Bladder Neoplasms

Carcinoma, Transitional Cell

Parkinson Disease 4, Autosomal Dominant Lewy Body, Urinary Bladder Neoplasms

Transitional Cell Bladder Cancer

Carcinoma, Transitional Cell

Urinary Bladder Neoplasms

Urinary Bladder Neoplasms

Urinary Bladder Neoplasms

Urinary Bladder Neoplasms, Ileus

Urinary Bladder Neoplasms

Clinical Trials

TRIFECTA

Gemcitabine and Cisplatin Without Cystectomy for Patients With Muscle Invasive Bladder Urothelial Cancer and Select Genetic Alterations

Sacituzumab Govitecan Before Radical Cystectomy for the Treatment of Non-Urothelial Muscle Invasive Bladder Cancer

A Study to Test the Safety of Immunotherapy With Nivolumab Alone or With Ipilimumab Before Surgery for Bladder Cancer Patients Who Are Not Suitable for Chemotherapy

A Study of Radiation Therapy and Cemiplimab With or Without Fianlimab In People With Bladder Cancer

Enfortumab Vedotin and Pembrolizumab With Cystectomy and/or Ureterectomy for Locally Advanced or Metastatic Bladder and Upper Urothelial Tract Cancer, CAST-AI Trial

REDEMPTED

VOLGA

Futibatinib in Combination With Durvalumab Prior to Cystectomy for the Treatment of Muscle-Invasive Bladder Cancer Patients Who Are Ineligible for Cisplatin-based Therapy

NEOBLAST

FUTURE

RAD-VACCINE

Window of Opportunity Study of Pembrolizumab Alone and in Combinations in Bladder Cancer

"NAC-MRI"

Pembrolizumab and Combination Chemotherapy Before Surgery for the Treatment of Muscle-Invasive Bladder Cancer

Assessment of Decision Tool to Select Women for Gynecologic Sparing Radical Cystectomy

KEYNOTE-866

Radical Cystectomy Versus Tri-Modal Therapy for Treatment of cT2N0M0 Urinary Bladder Transitional Cell Carcinoma

Cystoscopic Evaluation Predicting pT0 Urothelial Carcinoma of the Bladder

Atezolizumab Plus Etoposide and Platinum in Small Cell Bladder Cancer

DIVON

Role of NAC in cT0 Muscle-invasive Bladder Cancer After Maximal TURBt

CIMMIS

3 Tesla MRI in Patients With Bladder Cancer